These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 9290700

  • 1. Accelerated onset of uterine tumors in transgenic mice with aberrant expression of the estrogen receptor after neonatal exposure to diethylstilbestrol.
    Couse JF, Davis VL, Hanson RB, Jefferson WN, McLachlan JA, Bullock BC, Newbold RR, Korach KS.
    Mol Carcinog; 1997 Aug; 19(4):236-42. PubMed ID: 9290700
    [Abstract] [Full Text] [Related]

  • 2. Potentiation of diethylstilbestrol-induced alterations in the female mouse reproductive tract by transforming growth factor-alpha transgene expression.
    Gray K, Bullock B, Dickson R, Raszmann K, Walmer D, McLachlan J, Merlino G.
    Mol Carcinog; 1996 Nov; 17(3):163-73. PubMed ID: 8944077
    [Abstract] [Full Text] [Related]

  • 3. Developmental exposure to diethylstilbestrol alters uterine gene expression that may be associated with uterine neoplasia later in life.
    Newbold RR, Jefferson WN, Grissom SF, Padilla-Banks E, Snyder RJ, Lobenhofer EK.
    Mol Carcinog; 2007 Sep; 46(9):783-96. PubMed ID: 17394237
    [Abstract] [Full Text] [Related]

  • 4. Uterine tumors in old female mice exposed prenatally to diethylstilbestrol.
    Walker BE.
    J Natl Cancer Inst; 1983 Mar; 70(3):477-84. PubMed ID: 6572737
    [Abstract] [Full Text] [Related]

  • 5. Estrogen receptor-alpha knockout mice exhibit resistance to the developmental effects of neonatal diethylstilbestrol exposure on the female reproductive tract.
    Couse JF, Dixon D, Yates M, Moore AB, Ma L, Maas R, Korach KS.
    Dev Biol; 2001 Oct 15; 238(2):224-38. PubMed ID: 11784006
    [Abstract] [Full Text] [Related]

  • 6. The role of the estrogen receptor in diethylstilbestrol toxicity.
    Korach KS, McLachlan JA.
    Arch Toxicol Suppl; 1985 Oct 15; 8():33-42. PubMed ID: 3913404
    [Abstract] [Full Text] [Related]

  • 7. Mechanisms of DES carcinogenicity: effects of the TGF alpha transgene.
    Gray K, Bullock B, Dickson R, Raszmann K, McLachlan J, Merlino G.
    Prog Clin Biol Res; 1997 Oct 15; 396():217-31. PubMed ID: 9108600
    [Abstract] [Full Text] [Related]

  • 8. Expression of a dominant negative estrogen receptor alpha variant in transgenic mice accelerates uterine cancer induced by the potent estrogen diethylstilbestrol.
    Davis VL, Newbold RR, Couse JF, Rea SL, Gallagher KM, Hamilton KJ, Goulding EH, Jefferson W, Eddy EM, Bullock BC, Korach KS.
    Reprod Toxicol; 2012 Dec 15; 34(4):512-21. PubMed ID: 22989549
    [Abstract] [Full Text] [Related]

  • 9. Transplacental administration of diethylstilbestrol (DES) causes lesions in female reproductive organs of Donryu rats, including endometrial neoplasia.
    Kitamura T, Nishimura S, Sasahara K, Yoshida M, Ando J, Takahashi M, Shirai T, Maekawa A.
    Cancer Lett; 1999 Jul 01; 141(1-2):219-28. PubMed ID: 10454265
    [Abstract] [Full Text] [Related]

  • 10. Estrogen receptor-alpha mediates the detrimental effects of neonatal diethylstilbestrol (DES) exposure in the murine reproductive tract.
    Couse JF, Korach KS.
    Toxicology; 2004 Dec 01; 205(1-2):55-63. PubMed ID: 15458790
    [Abstract] [Full Text] [Related]

  • 11. Etiology of DES-induced uterine tumors in the Syrian hamster.
    Leavitt WW, Evans RW, Hendry WJ.
    Adv Exp Med Biol; 1981 Dec 01; 138():63-86. PubMed ID: 7342722
    [Abstract] [Full Text] [Related]

  • 12. Developmental exposure to diethylstilbestrol elicits demethylation of estrogen-responsive lactoferrin gene in mouse uterus.
    Li S, Washburn KA, Moore R, Uno T, Teng C, Newbold RR, McLachlan JA, Negishi M.
    Cancer Res; 1997 Oct 01; 57(19):4356-9. PubMed ID: 9331098
    [Abstract] [Full Text] [Related]

  • 13. Identification of a sensitive period for developmental programming that increases risk for uterine leiomyoma in Eker rats.
    Cook JD, Davis BJ, Goewey JA, Berry TD, Walker CL.
    Reprod Sci; 2007 Feb 01; 14(2):121-36. PubMed ID: 17636224
    [Abstract] [Full Text] [Related]

  • 14. Delayed adverse effects of neonatal exposure to diethylstilbestrol and their dose dependency in female rats.
    Yoshida M, Takahashi M, Inoue K, Hayashi S, Maekawa A, Nishikawa A.
    Toxicol Pathol; 2011 Aug 01; 39(5):823-34. PubMed ID: 21747122
    [Abstract] [Full Text] [Related]

  • 15. Estrogen receptor (ER) and its messenger ribonucleic acid expression in the genital tract of female mice exposed neonatally to tamoxifen and diethylstilbestrol.
    Sato T, Ohta Y, Okamura H, Hayashi S, Iguchi T.
    Anat Rec; 1996 Mar 01; 244(3):374-85. PubMed ID: 8742702
    [Abstract] [Full Text] [Related]

  • 16. Characterization of uterine leiomyomas in CD-1 mice following developmental exposure to diethylstilbestrol (DES).
    Newbold RR, Moore AB, Dixon D.
    Toxicol Pathol; 2002 Mar 01; 30(5):611-6. PubMed ID: 12371671
    [Abstract] [Full Text] [Related]

  • 17. Mice heterozygous for a Brca1 or Brca2 mutation display distinct mammary gland and ovarian phenotypes in response to diethylstilbestrol.
    Bennett LM, McAllister KA, Malphurs J, Ward T, Collins NK, Seely JC, Gowen LC, Koller BH, Davis BJ, Wiseman RW.
    Cancer Res; 2000 Jul 01; 60(13):3461-9. PubMed ID: 10910057
    [Abstract] [Full Text] [Related]

  • 18. Endometrial hyperplasia and apoptosis following neonatal diethylstilbestrol exposure and subsequent estrogen stimulation in both host and transplanted hamster uteri.
    Hendry WJ, Zheng X, Leavitt WW, Branham WS, Sheehan DM.
    Cancer Res; 1997 May 15; 57(10):1903-8. PubMed ID: 9157983
    [Abstract] [Full Text] [Related]

  • 19. Induction of estrogen receptor, peroxidase activity, and epithelial abnormalities in the mouse uterovaginal epithelium after neonatal treatment with diethylstilbestrol.
    Andersson C, Forsberg JG.
    Teratog Carcinog Mutagen; 1988 May 15; 8(6):347-61. PubMed ID: 2905546
    [Abstract] [Full Text] [Related]

  • 20. Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis.
    Newbold RR, Bullock BC, McLachlan JA.
    Cancer Res; 1990 Dec 01; 50(23):7677-81. PubMed ID: 2174729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.